Carboxypeptidase type II (prostate-specific membrane antigen—PSMA) is a transmembrane protein that is not only expressed on the surface of prostate cancer cells but also in neovascular endothelial cells of various solid malignancies, including RCC [8,9]. Here, FOLH1 is linked to prostate cancer.